Illumina, Inc. (ILMN) Competitors & Peers
The 5 largest companies in the same industry as Illumina, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Peer | $651.45 | P/E 35.5RSI 68Cap 240.9 B |
| DHR | Peer | $211.81 | P/E 37.6RSI 55Cap 148.3 B |
| NTRA | Peer | $369.39 | RSI 74Cap 53.2 B |
| IQV | Peer | $266.42 | P/E 33.2RSI 66Cap 43.9 B |
| A | Peer | $156.47 | P/E 30.9RSI 63Cap 44.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- GRALPartner
Grail was spun off from Illumina and utilizes Illumina next-generation sequencing systems for its Galleri tests.
Model-inferred, unverified — treat as a lead, not evidence - PACBCompetitor
PacBio + Illumina compete in long-read + short-read sequencing.
Model-inferred, unverified — treat as a lead, not evidence - ADPTCompetitor
Competes in immune research profiling and next-generation sequencing application segments.
Model-inferred, unverified — treat as a lead, not evidence - MRNASupplier
Moderna uses Illumina sequencing for vaccine + immune-response profiling.
Model-inferred, unverified — treat as a lead, not evidence